相关实验视频
Updated: Feb 26, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
住院的临床特征与psittacosis肺炎的疾病严重程度相关:一个回顾性研究
Jiaqi Li1, Yuanbo Xue2, Junjie Cui3
1Department of Critical Care Medicine, Nanjing Drum Tower Hospital, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, China.
对型肺炎的客观风险分层是具有挑战性的. 基线d-二次体,单细胞计数和乳酸脱酶 (LDH) 可以预测入院时的疾病严重程度,有助于临床管理.
科学领域:
- 传染性疾病 传染性疾病
- 肺部病理学 肺部病理学
- 临床病理学 临床病理学
背景情况:
- 由Clamydia psittaci引起的病性肺炎带来了诊断上的挑战.
- 在入院时客观严重性风险分层对于有效的临床管理至关重要,但仍然很困难.
- 确定可靠的疾病严重程度早期指标对于患者分拣和资源分配至关重要.
研究的目的:
- 评估入院时在肺炎患者中严重性风险分层的基线临床和实验室特征.
- 为了确定预测型肺炎严重后果的关键指标.
主要方法:
- 追溯分析60名被诊断患有松病肺炎的患者 (31名严重,29名不严重).
- 在入院后24小时内收集临床和实验室数据.
- 应用Firth惩罚后勤回归来确定疾病严重程度的预测因素.
主要成果:
- 严重的病例显示呼吸衰竭的频率更高,住院时间更长,并发症更多.
- 关键的分化实验室发现包括高C反应蛋白 (CRP),前素 (PCT),d-二分体,乳酸脱酶 (LDH),酸氨基转移酶 (AST) 和血液尿素 (BUN),以及较低的白蛋白和淋巴细胞计数.
- 费尔斯惩罚后勤回归确定了d-二次体,单细胞数和LDH作为严重性显著预测因素,该模型显示出良好的区分性表现 (AUC=0.888).
结论:
- 基线d-二次体,单细胞计数和LDH反映了不同的病理生理过程:凝血激活,炎症反应和全身组织损伤.
- 这些标志物提供了一个潜在的框架,用于客观的严重性风险分层在医院入院后的psittacosis肺炎.
- 客观风险分层可以帮助临床分类,并优化对患有肺炎的患者的资源配置.
更多相关视频
07:43A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice
Published on: September 28, 2016
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
相关概念视频
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: